Healthtech funding in Q2 2011

European Healthtech startup funding raised during Q2 2011.

In Q2 2011, 23 European Healthtech companies closed 23 funding rounds and raised €119M in equity funding (excluding debt and grants), down 9.8% versus Q2 2010. UK led by capital raised, and Enterprise Ireland was the most active investor. Data as of 6 Nov 2026.

Equity funding

€119M

-9.8% vs Q2 2010 · excl. debt & grants

Funding rounds

+64.3% vs Q2 2010

Companies

Top country

Rank among sectors

11.8% of sector funding

Top-10 round share

92.4%

of disclosed capital

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Apr	€30M	3
May	€44M	9
Jun	€46M	11

Top countries

by € raised

Data table

	Healthtech — top countries by capital, Q2 2011
UK	€36M
Israel	€27M
Sweden	€15M
Germany	€14M
Switzerland	€14M
Finland	€10M
Spain	€2.0M
Ireland	€1.3M

Stage mix

by € raised

Data table

	Healthtech — stage mix, Q2 2011
Series D+	€28M
Series C	€27M
Growth/Late	€27M
Series A	€17M
Series B	€8.1M
Early VC	€6.8M
Other	€3.1M
Seed	€2.4M

Top deals

largest disclosed rounds in Q2 2011

Company	Stage	Date	Amount
Oxford Nanopore Technologies	Series D+	Apr 2011	€28M
GenKyoTex	Series C	May 2011	€14M
BONESUPPORT	Growth/Late	Jun 2011	€13M
LifeBond	Series C	May 2011	€13M
Sapiens	Series A	Jun 2011	€13M
OrSense	Growth/Late	May 2011	€12M
Mendor	Series B	Jun 2011	€8.1M
Craneware	Early VC	Jun 2011	€4.2M
Nexstim	Other	May 2011	€2.0M
STAT-Diagnostica	Series A	Jun 2011	€2.0M
Crescent Diagnostics	Series A	Jun 2011	€1.5M
Lophius	Growth/Late	Jun 2011	€1.4M
Simplee	Seed	Apr 2011	€1.3M
Abcam	Early VC	Jun 2011	€1.3M
Scint-X	Other	May 2011	€1.1M

View all 23 Healthtech deals in Q2 2011 →

Top investors

most active in Q2 2011, by deal count

← All 2011 Healthtech funding